March 11 (Reuters) - Longeveron Inc LGVN.O :
* Q4 LOSS PER SHARE $0.20
* Q4 REVENUE $200,000
* JAPANESE PHASE 2 AGING FRAILTY TRIAL EXPECTED TO INITIATE IN FIRST HALF OF
2022
* BELIEVE THAT EXISTING CASH AND SHORT-TERM INVESTMENTS WILL BE SUFFICIENT
TO
COVER EXPENSES AND CAPITAL REQUIREMENTS INTO 2024
* CASH AND SHORT-TERM INVESTMENTS WAS $35.0 MILLION COMPARED TO $0.8 MILLION
AS OF
DECEMBER 31, 2021 AND 2020, RESPECTIVELY
Source text for Eikon: ID:nGNX6N9sy0
Further company coverage: LGVN.O
((Reuters.Briefs@thomsonreuters.com;))